Nanjing Regenecore Biotech Co., Ltd.
Clinical trials sponsored by Nanjing Regenecore Biotech Co., Ltd., explained in plain language.
-
New injection tested to help people breathe easier with COPD
Disease control Not yet recruitingThis study is testing whether an experimental injection called RC1416 can help people with moderate to severe COPD breathe better and have fewer serious flare-ups. About 180 participants will receive either the injection or a placebo shot every two weeks for one year. Researchers…
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
New asthma shot aims to help patients breathe easier
Disease control Not yet recruitingThis study is testing an investigational injection called RC1416 to see if it can help adults with moderate to severe asthma breathe better and have fewer serious asthma attacks. About 195 participants will receive either the drug or a placebo to compare results. The main goal is…
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC